Iodide

Iodide

SCHEMBL1618288

C[N+](C)(C)C(c1ccccc1)c1ccccc1.[I-]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.50
APOBEC3A P31941 1/20 0.43
APOBEC3G Q9HC16 1/20 0.43
SCN1A P35498 2/20 0.42
SCN2A Q99250 2/20 0.42
SCN3A Q9NY46 2/20 0.42
DPP4 P27487 2/20 0.39
F2 P00734 1/20 0.39
TSHR P16473 1/20 0.39
TAAR1 Q96RJ0 3/20 0.37
HTR2A P28223 2/20 0.37
HRH1 P35367 1/20 0.37
LMNA P02545 1/20 0.37
TRPA1 O75762 2/20 0.37
ADRA2A P08913 1/20 0.36
ADRA2C P18825 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1618600 0.97 CYP1A2 (0.52) CYP1A2APOBEC3AAPOBEC3GSCN1ASCN2A
Hydrochloric Acid SCHEMBL9420654 0.94 CYP1A2 (0.50) CYP1A2APOBEC3AAPOBEC3GSCN1ASCN2A
Water SCHEMBL3329824 0.94 CYP1A2 (0.50) CYP1A2APOBEC3AAPOBEC3GSCN1ASCN2A
Iodide SCHEMBL10961531 0.76 APOBEC3A (0.42) APOBEC3AAPOBEC3GSCN1ASCN2ASCN3A
SCHEMBL25261916 0.74 APOBEC3A (0.46) CYP1A2APOBEC3AAPOBEC3GSCN1ASCN2A
SCHEMBL3384297 0.72 TAAR1 (0.42) SCN1ASCN2ASCN3ADPP4F2
SCHEMBL3414483 0.72 TAAR1 (0.42) SCN1ASCN2ASCN3ADPP4F2
Iodide SCHEMBL14244499 0.70 SCN1A (0.37) CYP1A2APOBEC3AAPOBEC3GSCN1ASCN2A
SCHEMBL31648921 0.70 SRC (0.50) LMNA
SCHEMBL2987510 0.70 DPP4 (0.38) CYP1A2APOBEC3AAPOBEC3GSCN1ASCN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100078598-A1 CONDUCTIVE POLYMER COMPOSITION FOR RADIOGRAPHIC IMAGING ELPANI CO., LTD. (KR) 2010-04-01 US claimed
WO-2008091135-A1 CONDUCTIVE POLYMER COMPOSITION FOR RADIOGRAPHIC IMAGING ELPANI CO., LTD. (KR) 2008-07-31 WO claimed
US-12300507-B2 Method of manufacturing a semiconductor device TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2025-05-13 US disclosed
US-12112979-B2 Semiconductor device and manufacturing method thereof TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2024-10-08 US disclosed
US-20240186148-A1 METHOD OF MANUFACTURING A SEMICONDUCTOR DEVICE TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2024-06-06 US disclosed
US-11935757-B2 Method of manufacturing a semiconductor device TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2024-03-19 US disclosed
US-20230245900-A1 METHOD OF MANUFACTURING A SEMICONDUCTOR DEVICE TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) 2023-08-03 US disclosed
US-11626293-B2 Method of manufacturing a semiconductor device TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2023-04-11 US disclosed
US-20220301927-A1 SEMICONDUCTOR DEVICE AND MANUFACTURING METHOD THEREOF TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2022-09-22 US disclosed
US-20220230889-A1 METHOD OF MANUFACTURING A SEMICONDUCTOR DEVICE TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2022-07-21 US disclosed
US-11355388-B2 Semiconductor device and manufacturing method thereof TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) 2022-06-07 US disclosed
US-20100078598-A1 CONDUCTIVE POLYMER COMPOSITION FOR RADIOGRAPHIC IMAGING ELPANI CO., LTD. (KR) 2010-04-01 US disclosed
WO-2008091135-A1 CONDUCTIVE POLYMER COMPOSITION FOR RADIOGRAPHIC IMAGING ELPANI CO., LTD. (KR) 2008-07-31 WO disclosed
US-20080153991-A1 Method of making carbon nanotube patterned film or carbon nanotube composite using carbon nanotubes surface-modified with polymerizable moieties SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-06-26 US disclosed
US-20080020317-A1 Novel metal nanoparticle and formation of conductive pattern using the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-01-24 US disclosed
CN-100339766-C Preparations of carbon nano tube layout film or composite material from polymerisable semgental surface modified carbon nano tubes SAMSUNG ELECTRONICS CO LTD (KR) 2007-09-26 CN disclosed
US-7229747-B2 Surface treatment of interpenetrating polymer networkcarbon tubes; photolithography; heat curing; negative patterns SAMSUNG ELECTRONICS CO., LTD. (KR) 2007-06-12 US disclosed
US-20040265755-A1 Surface treatment of interpenetrating polymer networkcarbon tubes; photolithography; heat curing; negative patterns SAMSUNG ELECTRONICS CO., LTD. (KR) 2004-12-30 US disclosed
EP-1457821-A1 Method of making carbon nanotube patterned film or carbon nanotube composite material using a composition comprising carbon nanotubes surface-modified with polymerizable moieties Samsung Electronics Co., Ltd. (KR) 2004-09-15 EP disclosed
US-20030064307-A1 Process for forming latent image, process for detecting latent image, process and device for exposure, exposure apparatus, resist and substrate NIKON CORPORATION (JP) 2003-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153991-A1 Method of making carbon nanotube patterned film or carbon nanotube composite using carbon nanotubes surface-modified with polymerizable moieties FSCN1, NCDN, ACTN1 CYP1A2 902/4885APOBEC3A 3290/4885APOBEC3G 3051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.